Our team supports pharmaceutical and biotech companies in diverse projects across global, regional and local/CPO teams. The majority of our work is related to outcomes and value in real-world practice across Europe and the US.
Drawing on our global network of KOLs, our specialist staff embrace evidence-based medicine.
We are experts in aggregating data across disease registries, national statistics and primary and secondary care datasets.
We strive to build lasting relationships with clients based on our compliance, integrity and quality of deliverables.
Access to analysis from our expanding network of healthcare data sources to support medical affairs, commercial, and R&D operations.
End-to-end capability for deliverables using routine healthcare data.
We have a track record of supporting manuscripts to publication in high impact peer-reviewed journals.
We offer a full range of publication types including original research articles, meta-analyses and meta-regression, systematic reviews, and narrative reviews.
Our value-added services in medical writing include expert strategic insights for publication planning.
Health Economics and Outcomes Research
We have supported clients in establishing new capabilities and infrastructure in respect to post-market surveillance tools, to capture and monitor real-world data and outcomes.
Central to our ethos is the integration of technology and big data to improve the safety, effectiveness, and value of healthcare products and services.
Our in-house expertise in data analytics allows us to build and manage clinical and research networks supported by tailored databases, which can then be applied to quality improvement and outcomes programs, as well as comparative effectiveness analyses.
Evidence generation for regulatory submissions
Our expertise in systematic review, meta-analysis, meta-regression and health economics supports evidence review group submissions.
Comparative effectiveness studies.
Isolating product value in healthcare data.
Defining, capturing and measuring value in disease for providers, payors and industry.